Related Experiment Videos
Apolipoprotein E epsilon 4 in inclusion body myositis
M J Garlepp1, H Tabarias, F M van Bockxmeer
1Australian Neuromuscular Research Institute, Australia.
Annals of Neurology
|December 1, 1995
Summary
Genetic predisposition to inclusion body myositis (IBM) may involve apolipoprotein E (APO E) genotype. The APO E epsilon 4 allele, linked to Alzheimer's disease, was more frequent in IBM patients, suggesting a role in disease susceptibility.
Area of Science:
- Neurology
- Genetics
- Immunology
Background:
- Inclusion body myositis (IBM) is a rare, progressive muscle disease with likely multifactorial genetic causes.
- Beta-amyloid protein deposition is a shared feature of IBM and Alzheimer's disease (AD).
- The apolipoprotein E (APO E) epsilon 4 allele is a known risk factor for AD.
Purpose of the Study:
- To investigate the association between APO E genotype and IBM susceptibility.
- To compare APO E allele frequencies in IBM patients with control groups.
Main Methods:
- Genotyping of APO E alleles in 14 IBM patients.
- Comparison of allele frequencies with patients suffering from other inflammatory muscle diseases and the general population.
Main Results:
- The frequency of the APO E epsilon 4 allele was significantly higher in IBM patients (0.29) compared to other inflammatory muscle diseases (0.15) and the general population (0.13).
- Statistical analysis confirmed a significant difference (p < 0.05).
Conclusions:
- APO E genotype, specifically the epsilon 4 allele, may be a contributing genetic factor in the predisposition to developing inclusion body myositis.
- Further research is warranted to elucidate the precise role of APO E in IBM pathogenesis.